CAS: 85248-93-7; (E)-9-(((E)-4-((2S,3R,4R,5S)-3,4-Dihydroxy-5-(((2S,3S)-3-((2S,3S)-3-Hydroxybutan-2-yl)Oxiran-2-yl)Methyl)Tetrahydro-2H-Pyran-2-yl)-3-Methylbut-2-Enoyl)Oxy)Non-4-Enoic Acid

该化合物是源自Pseudomonas spp.的二代代代谢物,以其强效抗菌特性而著称;该化合物通过抑制细菌的同位素性乙酰基-tRNA合成酶,干扰蛋白合成,有选择性地对抗模性细菌,特别是抗血球菌素Aureus,特别是Staphylococccus Aureus进行有选择的活动;其行动机制降低了与其他抗生素类交叉抗药性的可能性,使其成为研究抗微生物发育的有价值的候选产品;二体酸D在结构上不同于其模拟物,mupirocin(假体酸A),在药用动力学和活动范围方面可能存在差异;主要用于实验室环境研究细菌抗药机制和新型抗生战略;高纯度可用于精确的实验应用.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      📜(Z)-9-((E)-4-{(2S,3R,4R,5S)-3,4-Dihydroxy-5-[(2S,3S)-3-((1S,2S)-2-Hydroxy-1-Methyl-Propyl)-Oxiranylmethyl]-Tetrahydro-Pyran-2-Yl}-3-Methyl-But-2-Enoyloxy)-Non-4-Enoic Acid Methyl Ester置于baker'S Yeast体系中,用 N,N-二甲基甲酰胺 作为反应溶剂,化学反应 18.0H,反应生成 Pseudomonic Acid D,莫匹罗星ep杂质c
      参考文献:O'Hanlon,Peter J.; Rogers,Norman H.; Tyler,John W.,Journal Of The Chemical Society. Perkin Transactions I,1983,# 11,P. 2655-2657
      标题:O'Hanlon,Peter J.; Rogers,Norman H.; Tyler,John W.,Journal Of The Chemical Society. Perkin Transactions I,1983,# 11,P. 2655-2657

      海关参考信息

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式

      主要参考文献


      1: Finnell SM, Rosenman MB, Christenson JC, Downs SM. Decolonization of children after incision and drainage for MRSA abscess: a retrospective cohort study. Clin Pediatr (Phila). 2015 May;54(5):445-50. doi: 10.1177/0009922814556059. Epub 2014 Nov 10. doi: 10.1007/s10719-014-9538-6. Epub 2014 Jul 30. doi: 10.1093/jac/dku522. Epub 2014 Dec 23. doi: 10.1021/jo200396q. Epub 2011 Jul 8. doi: 10.1089/sur.2012.086. Epub 2013 Feb 28. doi: 10.1016/j.jhin.2013.09.006. Epub 2013 Sep 21. Review. doi: 10.1016/j.ijmm.2013.03.003. Epub 2013 Mar 29. doi: 10.1097/CCM.0000000000000140. Chinese. doi: 10.1002/cbic.200900565. doi: 10.1016/j.jhin.2011.08.009. Epub 2011 Oct 2. doi: 10.1128/JCM.00302-12. Epub 2012 Jul 3.
      13: Shiozawa H, Shimada A, Takahashi S. Thiomarinols D, E, F and G, new hybrid antimicrobial antibiotics produced by a marine bacterium; isolation, structure, and antimicrobial activity. J Antibiot (Tokyo). 1997 May;50(5):449-52. doi: 10.4103/1947-2714.139293.
      15: Sit D, Kadiroglu AK, Kayabasi H, Yilmaz ME. Prophylactic intranasal mupirocin ointment in the treatment of peritonitis in continuous ambulatory peritoneal dialysis patients. Adv Ther. 2007 Mar-Apr;24(2):387-93. doi: 10.1016/j.jcot.2015.08.004. Epub 2015 Sep 11.
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知